[Main therapeutic advances in IBD in 2008]

C Felley; C Mottet; J Hess; M H Maillard; J Delarive; P Michetti

[Main therapeutic advances in IBD in 2008]

Rev Med Suisse. 2009 Jan 21;5(187):185-6, 188-90, 192-4.

[Article in French]

Authors

C Felley¹, C Mottet, J Hess, M H Maillard, J Delarive, P Michetti

Affiliation

¹ Service de gastroentérologie et d'hépatologie, CHUV, Lausanne.

PMID: 19271429

Abstract

A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia.

Publication types

English Abstract

MeSH terms

Chemoprevention
Gastrointestinal Agents / therapeutic use
Humans
Inflammatory Bowel Diseases / therapy*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Gastrointestinal Agents
Tumor Necrosis Factor-alpha